Radiation Exposure of Patients by Cone Beam CT during Endobronchial Navigation - A Phantom Study by Hohenforst-Schmidt, Wolfgang et al.
Wayne State University
Internal Medicine Faculty Publications Department of Internal Medicine
2-6-2014
Radiation Exposure of Patients by Cone Beam CT
during Endobronchial Navigation - A Phantom
Study
Wolfgang Hohenforst-Schmidt
University of Wuerzburg
Rosemarie Banckwitz
Siemens AG Healthcare Sector
Paul Zarogoulidis
Aristotle University of Thessaloniki
Thomas Vogl
Goethe University of Frankfurt
Kaid Darwiche
University Duisburg-Essen
See next page for additional authors
This Article is brought to you for free and open access by the Department of Internal Medicine at DigitalCommons@WayneState. It has been accepted
for inclusion in Internal Medicine Faculty Publications by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Hohenforst-Schmidt W, Banckwitz R, Zarogoulidis P, Vogl T, Darwiche K, Goldberg E, Huang H, Simoff M, Li Q, Browning R, Freitag
L, Turner JF, Pivert PL, Yarmus L, Zarogoulidis K, Brachmann J. Radiation Exposure of Patients by Cone Beam CT during
Endobronchial Navigation - A Phantom Study. J Cancer 2014; 5(3):192-202. doi:10.7150/jca.8395. Available from
http://www.jcancer.org/v05p0192.htm
Available at: https://digitalcommons.wayne.edu/med_intmed/6
Authors
Wolfgang Hohenforst-Schmidt, Rosemarie Banckwitz, Paul Zarogoulidis, Thomas Vogl, Kaid Darwiche,
Eugene Goldberg, Haidong Huang, Michael Simoff, Qiang Li, Robert Browning, Lutz Freitag, J. Francis
Turner, Patrick Le Pivert, Lonny Yarmus, Konstantinos Zarogoulidis, and Johannes Brachmann
This article is available at DigitalCommons@WayneState: https://digitalcommons.wayne.edu/med_intmed/6
Journal of Cancer 2014, Vol. 5 
 
 
http://www.jcancer.org 
192 
Journal of Cancer 
2014; 5(3): 192-202. doi: 10.7150/jca.8395 
Research Paper 
Radiation Exposure of Patients by Cone Beam CT 
during Endobronchial Navigation - A Phantom Study 
Wolfgang Hohenforst-Schmidt1, Rosemarie Banckwitz2, Paul Zarogoulidis3,4, Thomas Vogl5, Kaid 
Darwiche4, Eugene Goldberg6, Haidong Huang7,8, Michael Simoff8, Qiang Li7, Robert Browning9, Lutz 
Freitag4, J Francis Turner10, Patrick Le Pivert11, Lonny Yarmus12, Konstantinos Zarogoulidis3, Johannes 
Brachmann1 
1. II Medical Clinic, Coburg Hospital, University of Wuerzburg, Coburg, Germany; 
2. Siemens AG Healthcare Sector, Forchheim, Germany; 
3. Pulmonary Department-Oncology Unit, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; 
4. Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Center, University Hospital, University Duisburg-Essen, Essen, Germany; 
5. Department of Diagnostic and Interventional Radiology, Goethe University of Frankfurt, Frankfurt, Germany; 
6. Biomaterials Science and Engineering, Department of Materials Science and Engineering, University of Florida, FL, USA; 
7. Department of Respiratory Diseases, Changhai Hospital/First Affiliated Hospital of the Second Military Medical University, Shanghai, People’s Republic of 
China; 
8. Bronchoscopy and Interventional Pulmonology, Pulmonary and Critical Care Medicine, Henry Ford Hospital, Wayne State University, School of Medicine, 
MI, USA; 
9. Pulmonary and Critical Care Medicine, Interventional Pulmonology, National Naval Medical Center, Walter Reed Army Medical Center, Bethesda, MD, 
USA; 
10. Pulmonary Medicine, University of Nevada School of Medicine, National Supercomputing Center for Energy and the Environment University of Nevada, 
Las Vegas, NV, USA; 
11. Interventional Drug Delivery Systems and Strategies (ID2S2), Medical Cryogenics, Jupiter, FL, USA; 
12. Division of Pulmonary and Critical Care Medicine, Sheikh Zayed Cardiovascular & Critical Care Tower, Johns Hopkins University, Baltimore, U.S.A.  
 Corresponding author: Paul Zarogoulidis, Pulmonary Department, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki. Thessaloniki, 
Greece. Fax: 00302130992433 Mobile: 00306977271974 Email: pzarog@hotmail.com. 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2013.12.19; Accepted: 2014.01.23; Published: 2014.02.06 
Abstract 
Rationale: Cone Beam Computed Tomography imaging has become increasingly important in 
many fields of interventional therapies. Objective: Lung navigation study which is an uncommon 
soft tissue approach. Methods: As no effective organ radiation dose levels were available for this 
kind of Cone Beam Computed Tomography application we simulated in our DynaCT (Siemens 
AG, Forchheim, Germany) suite 2 measurements including 3D acquisition and again for 3D ac-
quisition and 4 endobronchial navigation maneuvers under fluoroscopy towards a nodule after the 
8th segmentation in the right upper lobe over a total period of 20 minutes (min). These figures 
reflect the average complexity and time in our experience. We hereby describe the first time the 
exact protocol of lung navigation by a Cone Beam Computed Tomography approach. Meas-
urement: The hereby first time measured body radiation doses in that approach showed very 
promising numbers between 0,98-1,15mSv giving specific lung radiation doses of 0,42-0,38 mSv. 
Main results: These figures are comparable or even better to other lung navigation systems. 
Cone Beam Computed Tomography offers some unique features for lung interventionists as a 
realtime 1-step navigation system in an open structure feasible for endobronchial and 
transcutaneous approach. Conclusions: Due to this low level of radiation exposure Cone Beam 
Computed Tomography is expected to attract interventionists interested in using and guiding 
endobronchial or transcutaneous ablative procedures to peripheral endobronchial and other lung 
lesions. 
Key words: Dyna CT, lung cancer, diagnosis. 
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Introduction 
Cone Beam Computed Tomography (CBCT) 
imaging has become increasingly important during 
lung navigated interventions, demonstrating a fact 
that is correlated with modern endoscopic and im-
age-guided diagnostic and/or therapeutic modalities 
addressing thoracic malignancies.[1-11] First reports 
on medical navigation during thoracic surgical pro-
cedures such as from the SHG Hospital Voelklingen, 
Germany and University Hospital, Saga, Japan (Cus-
tomer Magazine AXIOM Innovations November, 
2012) paved the way to advanced thoracic operative 
theaters in that they allow multimodal interventional 
approaches. However CBCT navigation carries an 
additional radiation exposure to patient and operator, 
which has not been measured or published for lung 
procedures to this day. Modern CBCT configurations 
allow the standard 2-dimensional (2D) projection 
functionality like fluoroscopy as well as volumetric 
computed tomography (CT) capabilities within the 
interventional suite. For acquisition of the 
3-dimensional (3D) dataset the C-arm of CBCT needs 
to rotate by at least 200° (180° plus fan angle) around 
the target that has to remain stationary during acqui-
sition.[12] For our lung image acquisition we use the 5 
seconds (s) run with 248 single 2D-projections with a 
30cm*40cm head. Our protocol is providing sufficient 
image quality for clearly displaying the bronchial 
structures as well as the target itself. (Figure 1) These 
data are sent automatically to a workstation where the 
reconstruction is completed within less than 15s. At 
the workstation the target itself as well as the path 
within the bronchial tree are identified and marked 
with manual annotation tools (Siemens iguide 
toolbox). Afterwards these markers are projected and 
overlaid to the fluoroscopic image. (Figure 2) This 
technique allows the physician to match his instru-
ments to the overlay and in consequence navigate 
correctly to the (sometimes fluoroscopy-invisible) 
target. The major limitation of this technique is sig-
nificantly poorer image quality if there is target mo-
tion during 3D acquisition. For eliminating this factor 
the absence of spontaneous respiration is mandatory – 
the patient has to be put into apnea. The connected jet 
ventilation system (TwinStream, Carl Reiner, and 
Austria) is maintaining the inspiration phase during 
acquisition and navigation process. This leads to an 
accurate match between the 3D dataset and the 
fluoroscopic image. At the same time maintained in-
spiratory ventilator set-up with high inspiratory 
pressures (e.g. at least over 2,5bar) over e.g. 12s hy-
perinflates the lung. This offers good visualization of 
bronchioli smaller 3mm in diameter after the 7th-8th 
segmentation. (Figure 3, 4) When used in normofre-
quent jet-ventilation (e.g. jet-ventilation with respira-
tory frequency (RF) 80/min with inspira-
tion-exspiration ratio (I: E) of 1:1,5) standard inspira-
tory working pressures (SIWP) initially are set up 
along the weight of a patient: (SIWP) (bar) = (weight 
(kg)*0,015) with a fractional inspiratory oxygen con-
centration (FIO2) 0,8-1. To perform 3D data acquisi-
tion under hyperinflation it is necessary to change the 
set-up of the ventilator to RF 2/min with an I: E 3:1 
giving at least 15s of maintained hyperinflation 
without any movement: During this period there is 
perfect alignment between the virtual anatomy de-
rived from the 3D data acquisition overlaid in fluoro 
imaging and the real anatomy. To reach the optimal 
hyperinflation the SIWP is elevated in steps of 0,5bar 
until a peak inspiratory pressure (PIP) measured at 
the tip of the double lumen jet-catheter (Acutronic, 
Medical Systems, Switzerland) reaches 40mbar. (Fig-
ure 5) The positioning of the jet-catheter is performed 
by seldinger technique with use of a pulmonary 
jag-wire (Boston Scientific, USA). 
 
Figure 1. A) DynaCT with a bit of motion artefact, B) Right: HRCT 1mm nearly same level; slices same patient (2 adeno-carcinomas: *) Showing the same 
nice details (arrows at the same position indication bronchioli of 2mm and less). 
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Figure 2. A) DynaCT with carcinoid*Arrows indicating small bronchioli subpleural. B) Right: iguide toolbox with the same dataset before annotation of the 
path and target volume. 
  
 
Figure 3. A) Dotting the pathway in the 3 standard axis, B) Segmentation and dotting of the SPN in the 3 standard axis, C) Overlay in fluoroscopy (different 
patients). 
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Figure 4. An example of navigation up to a SPN after the 8th segmentation (counted from the main carina). 
  
Figure 5. Jet-catheter inserted in trachea in DynaCT (arrows). 
 
Materials and Methods for radiation ex-
posure measurements 
The male Alderson-Rando phantom (The Phan-
tom RANDO®, Alderson Research Laboratories Inc., 
Stamford, CT, USA) (mARp) is an anthropomorphic 
phantom which can be equipped with dosimeters. 
(Figure 6.) It consists of a human skeleton which is 
embedded in a rubber composition with isocyanate 
having a specific density of 0.985 g/cm ³ along with 
absorption and scattering properties to X-rays equiv-
alent to those of the human tissue. 
The height of the limb-less body phantom is 173 
cm, its weight amounts 73.5 kg. The sagittal diameter 
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of the abdomen measures 22 cm. The phantom can be 
disassembled into 2.5 cm thick, axial slices. Each layer 
is provided with holes meant for holding dosimeters. 
These dosimeters are thermoluminescense detectors 
(TLD). These detectors are based on the emission of 
thermoluminscence (TL) on heating of previously 
exposed crystalline materials. The intensity of the 
emitted TL is a function of the dose deposited in the 
material, and can therefore be used for dosimetry. 
Calibration of TLD 
In TLD with the same time-radiation history i.e. 
always irradiated, analyzed and regenerated together 
at the same time, the change in the calibration factor is 
approximately equal. 
Therefore, the TLDs are summarized in batches 
which always pass together through a measurement 
cycle. A batch is always divided into two fractions 
during a measurement. The first fraction (F1) is sub-
jected to a calibration irradiation at a defined dose (1 
Gy) to determine the change in the calibration factor. 
This change of calibration factor can be applied to the 
second fraction (F2) which is used for the actual 
measurement of the radiation dose. 
As a TLD for the organ dose measurements 
serves Lithium-Fluorid-thermoluminescence dosime-
ters (The Harshaw Chemical Company, Chrystal and 
Electronics Products Department, Solon, Ohio, USA) 
(TLD-100 rods, 1 x 1 x 6 mm). The locations are se-
lected on the basis of a CT atlas. Three TLD rods were 
packed in plexiglass tube and then inserted into the 
corresponding holes of the respective layer of the 
mARp. For dose measurements with the mARp 150 
TLDs were fitted to 43 different measuring points. 
TLD-Reader 
The TLD rods were stabilized C 
("pre-annealing") and analysed in the next hours fol-
lowing the investigation for 10min at 100°. The TLD 
reader used is an analyzer type Harshaw. For these 
analyses the TLDs are placed in an evaluation unit 
which provides at the same time for heating and for 
transmitted light detection during the heating pro-
cess. For light detection photomultiplier (PM) are 
used. The electric current generated by transmitted 
light during the heating process is proportional to the 
amount of light emitted from the TLD. Before each 
measurement a current measurement under dark 
conditions is carried out to ensure a constant PM sen-
sitivity. The dosimeters are heated in 20 s with a linear 
increase in temperature to 270°C. The measured val-
ues are adjusted by the background radiation, which 
is determined by fraction F1 of each TLD-rod batch. 
Each organ dose results from the average of the ad-
justed data from the three TLD rods per measurement 
point. A backscatter correction of the measured values 
for the dose is performed. From the different meas-
ured values of organ doses finally the effective patient 
dose is calculated. 
Calculation of the effective patient dose 
The effective dose (otherwise known as the ef-
fective dose equivalent) is a measure of radiation ex-
posure of humans. To calculate the effective dose 
(Deff) the organ doses (HT) are multiplied by the tis-
sue weighting factor (wT) of each organ (T). The sum 
of such weighted organ doses results in the effective 
(whole body) dose in Sievert (Sv): 
 
The tissue weighting factors were used by us in 
accordance with the current recommendations of the 
International Commission on Radiological Protection 
(IRCP). [13] The dose-area product has been stored for 
the entire investigation. 
 
Figure 6. The male Rando Alderson phantom 3edge angulations with 3 different views at least 30 degrees different to each other and with one oblique 
view. 
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Dose-Area product (DAP) 
The DAP was recorded using a panel attached to 
the ionization measurement chamber and by a reader 
(Diamentor M3, PTW, Freiburg, Germany) the value 
appeared in "cGycm²". 
It is calculated by multiplying the ionization in 
air (air kerma [cGy]) in the measurement chamber 
with the irradiated area [cm²]. The DAP and the 
fluoroscopy time were recorded separately for the 
above mentioned subsequent simulated investigation 
over 20min. Furthermore, the kV and mA values were 
recorded. 
Our standard protocol of specific jet-ventilation 
with deep sedation in complete apnea for the purpose 
of CBCT guided endobronchial navigation consists of 
the following steps: 
1. Seldinger-technique for jet-catheter position-
ing in the middle part of the trachea. 
2. Initiation of sedation protocol to achieve very 
low frequency of spontaneous breathing near apnea 
with remifentanil- (0,05ug/kg/min) and 
propofol-perfusors (4mg/kg/h). For definite apnea 
during data acquisition we used additional boli of 
50mg propofol. In case of low blood pressure we ap-
plied saline 0,9% and sometimes akrinor (Ratiopharm, 
Germany; 2ml consists of cafedrinhydrochlorid 
200mg and theodrenalinhydrochlorid 10mg as main 
drugs), in case of low heart frequency less than 
50/min we applied atropine (B. Braun, Germany; 
0,5mg/ml). 
3. Bronchoscopic control of the jet-catheter posi-
tion after nasal fixation to avoid direct objection 
against any endoluminal obstacle and introduction of 
an oral Guedel tube to keep pharynx and mouth open. 
4. Application of the above mentioned low fre-
quency inversed ratio jet-catheter set-up with FIO2 
100% and uptitration of the SIWP up to a PIP of 
40mbar. The maximum allowed SIWP is 3,5bar. By 
this means we achieve maximal tolerable hyperinfil-
tration. 
5. Establishing complete apnea by the use of ad-
ditional propofol boli for data acquisition under con-
stant hyperinflation with CBCT. 
6. Annotation of the path and the target with the 
Siemens toolbox and overlay of this 3D-information in 
the fluoroscopy image. 
7. In a situation of navigational decision the same 
ventilator set-up as during data acquisition has to be 
applied in order to guarantee perfect alignment of the 
virtual path and target volume with natural anatomy. 
8. Navigation control is achieved by the so called 
3-edges-angulation during this period of perfect 
alignment. From a posterior-anterior position of the 
DynaCT-head one has to angulate thirty degrees lat-
eral, then follow with another angulation of thirty 
degrees caudal or cranial and finally angulate thirty 
degrees medial. (Figure 7.) The examiner has to com-
pare these 3 views of the used endobronchial probe 
under fluoroscopy with the virtual anatomy overlaid 
in the fluoroscopy image: If we observe that the probe 
in all views stays in the virtual path segmentation or 
the target volume we can conclude that it has reached 
the desired anatomical position endothoracically. The 
number of 3-edges angulations needed depends on 
the complexity of the path and the endoluminal entry 
into the target. During the examination time when no 
navigational decision is needed we apply normofre-
quent jet-ventilation (e.g. RF 80/min; I: E 1:1, 5; SIWP 
in regards to blood gases). 
9. Biopsy is performed within the second of the 
manual stop of the ventilator set-up to avoid periph-
eral pneumothorax under hyperinflation. Repeated 
biopsies are done without additional 3-edges- 
angulations via an applied sheath which was used 
with first biopsy put over the instrument. 
 
 
Figure 7. 3edge angulations with 3 different views at least 30 degrees 
different to each other and with one oblique view. 
 
Results 
With the following standard program on our 
ceiling-mounted Artis Zee we found a whole body 
effective radiation dose of 0,98mSv under CBCT data 
acquisition for a SPN in the RUL. Adding 4 maneu-
vers of endobronchial lung navigation towards a SPN 
after the 8th segmentation in the RUL over 20min this 
dose increased to 1,15mSv for acquisition and naviga-
tion. (Tables 1, 2) 
Coro 40 Log Dyna CT Cardiac; 5sec untriggered; 
91kV,344mA, 3,9ms,1859,9µGym², 62,6mGy: 0,98-1,15 
mSv 
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Table 1. Measured radiation doses in the mARp during acquisi-
tion. 
Organ Organ dose 
(mSv) 
Weighting 
factor  
Effective dose 
(mSv) 
brain 0,14 0,01 0,001 
thyroid 1,03 0,04 0,041 
lung 3,53 0,12 0,424 
bone marrow 1,94 0,12 0,233 
esophagus 4,47 0,04 0,179 
thymus 4,00 0,01 0,040 
breast 0,00 0,12 0,000 
liver 0,14 0,04 0,006 
stomach 0,11 0,12 0,013 
spleen 0,05 0,01 0,001 
adrenal glands 0,15 0,01 0,002 
pancreas 0,12 0,01 0,001 
left kidney 0,07 0,01 0,001 
small intestine 0,00 0,01 0,000 
colon 0,00 0,12 0,000 
ilopsoas muscle 0,00 0,01 0,000 
ovar / testes 0,00 0,08 0,000 
uterus 0,00 0,01 0,000 
bladder 0,00 0,04 0,000 
bone surface 0,38 0,01 0,004 
skin 0,40 0,01 0,004 
other organs 0,56 0,06 0,034 
total   1,00 0,982 
 
Table 2. Measured radiation doses in the mARp during acquisi-
tion and 4 navigation maneuvers towards a SPN in the RUL after 
the 8th segmentation. 
brain 0,17 0,01 0,002 
thyroid 6,34 0,04 0,254 
lung 3,18 0,12 0,382 
bone marrow 1,83 0,12 0,220 
esophagus 4,48 0,04 0,179 
thymus 4,86 0,01 0,042 
breast 0,00 0,12 0,000 
liver 0,10 0,04 0,004 
stomach 0,08 0,12 0,010 
spleen 0,03 0,01 0,000 
adrenal glands 0,05 0,01 0,000 
pancreas 0,08 0,01 0,001 
left kidney 0,05 0,01 0,000 
small intestine 0,03 0,01 0,000 
colon 0,03 0,12 0,004 
ilopsoas muscle 0,03 0,01 0,000 
ovar / testes 0,06 0,08 0,005 
uterus 0,00 0,01 0,000 
bladder 0,01 0,04 0,000 
bone surface 0,28 0,01 0,003 
skin 0,30 0,01 0,003 
other organs 0,66 0,06 0,041 
total   1,00 1,147 
 
Discussion 
There is a high need for navigation in the lung to 
improve the diagnostic yield for SPNs, especially for 
SPNs < 3 cm or for fluoroscopy transparent nodules 
[14] where conventional bronchoscopy shows very 
limited diagnostic yield. This is in contrast to the fact 
that the principle rule’’ the earlier the diagnosis, the 
better the prognosis of an oncologic disease’’ espe-
cially counts for the size of an incidental lung cancer 
according to current guidelines.[15] Different elec-
tromagnetical navigation (EMN) techniques for en-
dobronchial approach have been developed in the last 
years aiming to improve the diagnostic yield. They 
are based on a low power magnetic resonance field in 
which the patient with magnetic sensors fitted in-
struments is explored by the help of a preceeding 
CT-data-acquisition.[16-19] This preceeding 
CT-dataset is overlaid and corrected by typical land-
marks (e.g. carinas) of the existing anatomy given by 
realtime bronchoscopy views. By this fusion and the 
identification of the instrument position in the 
3-dimensional volume this technique can produce 
’’realtime’’ virtual anatomy pictures beyond central 
airways which is then processed in a way to increase 
the ability of examiners to reach distal SPNs. It has 
been shown that EMN bronchoscopy provides a su-
perior diagnostic yield of 59-74% in SPN compared to 
standard transbronchial biopsy with an acceptable 
rate of complications mainly pneumothorax. [16-23] 
Diagnostic yield can be increased if a radial ultra-
sound probe is used to visualize the lesion and 
therefore prove that the tip of the extended working 
channel ends in the target zone. [16] An additional CT 
has to be performed as most of the CT scans during 
the initial diagnostic work-up do not fulfill the criteria 
necessary for EMN systems. In the end an EMN pro-
cedure is a 2-steps method: Data acquisition does not 
take place in the same examination set-up as for tak-
ing biopsies or local treatment. Most EMN systems do 
not offer a transthoracical approach. High acquisition 
and maintenance costs prevent a wide spread of this 
technique until now. From our view there are the fol-
lowing substantial differences between 2-steps EMN 
methods and real-time extrathoracical 1-step 
CBCT-navigation: 
Firstly, in EMN bronchoscopy the essential pre-
ceding CT-dataset is an additional radiation exposure 
for the patient which is higher than the radiation ex-
posure by CBCT navigation in average (Table 
3,4,5,6,7.) Secondly, the major disadvantage of a 2 
steps-method is the fact that the preceeding 
CT-dataset is made during deep inspiration bending 
down the diaphragm for a susbtantial height of sev-
eral centimeters especially for SPNs in the lower 
lobes. This position of the diaphragm is completely 
different to the situation under conventional or navi-
gated bronchoscopy by the help of the above men-
tioned systems as bronchoscopies are performed un-
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der deep sedation in reduced spontaneous breathing 
pattern which normally elevates the diaphragm until 
the functional residual capacity of the patient’s lung is 
reached. This means a great difference between the 
preceeding dataset and real-time true anatomy due to 
diaphragm recoil. Although there are efforts in some 
EMN systems (like Veran Technology) to compensate 
respiratory movement during navigation it is still a 
2-steps method. Thirdly, the proceeding CT-dataset is 
not performed on the same table at the same time in 
the same organ and patient position in the same place 
as with our protocol with CBCT. In case there is no 
organ and patient movement there is in principal 
perfect alignment of virtual 3D-dataset of 
CBCT-acquisition and realtime true anatomical posi-
ton during endobronchial navigation. Moreover; ex-
trathoracical navigation by CBCT for endobronchial 
purpose is delivering the possibility of using the 
’’unoccupied’’ working channel of bronchoscopes for 
conventional instruments. Our method with CBCT 
can perform continous endobronchial guidance and at 
the same time allow regular bronchoscopy perfor-
mances and maybe in future endobronchially driven 
ablative local therapies. Furthermore, EMN naviga-
tion does not offer a CT-similar function for trans-
thoracical approach as CBCT does: One may choose in 
regards to the localisation of a SPN the access – en-
dobronchial or transthoracical. Concerning additional 
radiation exposure to patients the hereby first time 
measured effective whole body radiation dose as 
mentioned above is in comparison to other 
CT-applications in chest medicine a very low figure. 
Possible explanations for this very low figure could be 
attributed to the following: 
Firstly, an excentric patient position for imaging 
of one (right) lung which would have induced less 
radiation exposure. During our simulation at the 
phantom we clearly averted this faulty position. Sen-
condly, in MSCT-acquisition the whole body diameter 
of a patient is exposed to radiation which is not true 
for CBCT-acquisition: The restriction by the geometry 
of the flat panel detector and the zoom-factor causes 
the so called field of view which is a cylindric volume 
of a certain diameter smaller than the normal whole 
body volume. This reduces again radiation exposure. 
Thirdly, as the most navigation cases take place in the 
right lung the dose measurements were performed for 
right lung upper field. One has to remember that ef-
fective dose is based on x-ray sensitivity of organs. 
Right lung is located away from stomach (with tissue 
factor 0,12) and close to liver (tissue factor 0,05). This 
makes in the end a reduction of a few percentages of 
the whole body effective radiation dose. Compared to 
other thoracic CBCT applications such dose is quite 
low [24] and allows from a radiation hygienic point of 
view to use this technique generously for evaluation 
and treatment of thoracic lesions. This dose is at least 
1/3 less than the dose that was used in the National 
Lung Screening Trial (NLST) in the United States.[25] 
Compared to conventional CT guidance for transtho-
racic approaches CBCT navigation reduces the radia-
tion exposure up to 42% during transcutaneous ap-
proach.[26] The use of endobronchial navigation for 
bronchoscopic tissue biopsy in a conventional mul-
ti-slice CT with low-dose protocols (MDCT) is com-
parable in radiation effective organ doses to 
patient.[27, 28] (Table 3.) Conversely to the closed 
MDCT configuration, the open CBCT structure allows 
for an easy access to the patient giving an advantage 
in coping with possible interventional complications. 
The hereby first time described technique has the po-
tential to improve the determination and treatment of 
smaller incidental solitary pulmonary nodule (SPN) 
that are partially invisible under conventional fluor-
oscopy compared to the results of conventional 
bronchoscopy. [14] In the future we believe that CBCT 
guided interventions will be the standard of care for 
any kind of focal procedures like endoluminal or 
endovascular navigation, transthoracical or endolu-
minal thermal ablation, local chemotherapy or other 
minimal-invasive procedures – in surgical or 
non-surgical interventional settings. Besides the 
above mentioned approaches in CBCT guided tho-
racical surgery some approaches have been made in 
the last years in different new therapeutic fields [1, 
29]. Very recently the combination of electromagnetic 
navigation devices and common CT-technology 
showed higher efficacy in transthoracical lung abla-
tion procedures compared to standard CT-guidance 
alone [30]. One can assume that this combination may 
improve the qualities of CBCT-guided interventions 
in future in a similar way. A CBCT-suite should be 
used by all kinds of interventional departments. Due 
to his qualities in 2D- and 3D-imaging, fusion capa-
bilities, local flexibility and patient friendly 
easy-to-access feasibility it will be the central part of 
hybrid rooms. It may be therefore an instrument to 
urge different medical specialties to cross over their 
very individual borders of interventional knowledge 
in the sense of real translational medicine: Get to-
gether in the CBCT-suite and take the best of all in-
terventional worlds. 
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Table 3. Examples of (mean) effective total body doses in examination types of heart, lung, head and abdomen (soft tissue) with CBCT 
or conventional XR- or CT-technique. 
Examination type mean eff. patient dose (mSv) Ref. 
Heart (EP), 30cm*40cm head CBCT (biplane) 
(only 3D-data acquisition) 
6,6 24 
Heart (EP), XR guided 8,3 (per hour) 7 
Heart (EP), XR guided, normal weight 15,2 (per 5,3 hour) 8 
Heart (EP), XR guided, overweight 26,7 (per 5,3 hour) 8 
Heart (EP), XR guided, obese 39,0 (per 5,3 hour) 8 
Lung (MDCT) (*) 2 12 
Lung (standard thoracic CT, MSCT) 7-8 11,12,26 
Triple-rule-out CT-angiography, 256-MSCT 6,5(male)-3,8(female) 6 
Head protocol, CBCT (2 different systems) 4,4-5,4 9 
Head protocol, MDCT 4,3 9 
Abdomen, 2 protocols each, CBCT (2 different systems) 15-37 9 
Abdomen, 2 protocols, MDCT 9,8-13,5 9 
Percutaneous transthoracic needle biopsy of pulmonary nodules < 1cm, CBCT 5,72mSv 10 
Endobronchial lung navigation (MDCT) 0,55-0,7 28 
Endobronchial lung navigation, 30cm*40cm head CBCT 0,98-1,15 our study 
EP: Electrophysiology. XR: Fluorscopy. (*) National Lung Screening Trial in the USA. MSCT (multiple slice CT). MDCT (multiple slice low-dose CT). 
 
Table 4. Examples of mean effective patient doses in milisievert (mSv) in classical XR-guided interventions consisting of radiography and 
repeated fluoroscopy. 
Examination type Radiography Fluoroscopy Total radiation exposure 
Abdominal angiography 3,1 5,1 8,2 
Arteriography of lower limbs 3,8 2,4 6,2 
Biliary drainage 1,8 36,4 38,2 
Embolization of spermatic vein 0,4 16,9 17,3 
Nephrostomy 0,9 12,7 13,6 
 
Table 5. Effective doses of different organs in orthopedics / trauma surgery: Comparison of conventional XR guided approach vs. 
CBCT-navigated approach. 
Spine surgery Sacroiliac joint 
Organ CBCT navigated XR guided conventional CBCT navigated XR guided conventional 
ovar 0,03 0,97 0,45 4,59 
testis 0,04 0,83 0,16 0,79 
red bone marrow 0,61 22,48 2,31 14,39 
sigmoid/Rectum 0,05 2,22 1,23 3,24 
lung 0,03 0,17 0,04 0,14 
stomach 1,55 8,28 0,08 0,23 
bladder 0,07 3,47 0,32 1,88 
liver 1,18 3,30 0,07 0,33 
esophagus 0,02 0,09 0,04 0,08 
thyroid 0,00 0,09 0,01 0,02 
Bone surface 0,46 1,68 0,16 0,79 
others 1,02 10,47 0,38 1,14 
Adrenal gland 1,15 4,68 0,10 0,40 
brain 0,00 0,02 0,00 0,03 
small bowel 1,43 31,14 0,28 0,92 
kidney 1,79 13,26 2,35 0,74 
pancreas 1,09 4,79 0,09 0,30 
spleen 2,59 16,96 0,16 0,43 
thymus 0,00 0,06 0,02 0,06 
colon  1,16 22,32 2,07 2,82 
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Table 6. Effective total body doses in different phantoms on a biplane CBCT. 
 Programs on Axiom Artis, syngo DynaCT 20*20cm2 biplane flat panel CBCT 
5sDRc without grid 5sDRc with grid Low Dose 5sDR-L 0,2Cu (with grid) 
 male female male female male female 
Clifford 0.192 0.272 0.219 0.326 0.050 0.072 
Braden 0.205 0.272 0.315 0.392 0.058 0.068 
Alderson  0.730 0.282 
The effective dose according to ICRP103 separate for each program, phantom and gender. The values are given in milli Sievert (mSv). Clifford and Braden are hermaphro-
dite, Alderson is a male phantom. Alderson did not undergo the 5sDRc diagnostic program without grid. 
A 10kg model “Clifford” represents children with an age of 0.5-3 years. 
A 19kg model “Braden” represents children with an age of 3-7 years. 
A 73kg model “Alderson” represents an adult person (as in our study). 
 
Table 7. Effective organ doses on Axiom Artis, syngo DynaCT, 20*20cm2 biplane flat panel CBCT in different phantoms. 
 
Organ/tissue 
Clifford Braden Alderson 
5sDRc  
without 
grid 
5sDRc  
with grid 
Low Dose 
5sDR-L 0.2Cu 
(with grid) 
5sDRc  
without grid 
5sDRc  
with grid 
Low Dose 
5sDR-L 0.2Cu 
(with grid) 
5sDRc  
with grid 
Low Dose 
5sDR-L 0.2Cu 
(with grid) 
brain 0.04 0.03 0.00 0.01 0.02 0.00 0.00 0.01 
thyroid 0.75 0.33 0.19 0.06 0.08 0.03 0.08 0.01 
lung 0.87 1.19 0.23 0.89 1.28 0.23 2.87 1.21 
red bone marrow 0.09 0.12 0.02 0.31 0.47 0.09 1.29 0.51 
esophagus 0.78 0.60 0.20 1.06 1.50 0.32 3.86 1.24 
thymus 0.87 1.10 0.22 0.90 1.25 0.25 1.03 0.45 
breast 0.65 0.88 0.19 0.64 0.83 0.15 - - 
liver 0.03 0.03 0.01 0.03 0.08 0.00 0.17 0.06 
stomach 0.03 0.04 0.01 0.02 0.08 0.00 0.18 0.07 
spleen 0.06 0.10 0.02 0.02 0.06 0.00 0.11 0.02 
adrenal gland 0.07 0.09 0.02 0.03 0.06 0.00 0.19 0.07 
pancreas 0.05 0.12 0.02 0.01 0.08 0.00 0.16 0.05 
left kidney 0.03 0.06 0.00 0.02 0.03 0.00 0.09 0.05 
small intestine 0.02 0.03 0.01 0.00 0.02 0.00 0.00 0.00 
colon 0.01 0.02 0.00 0.00 0.04 0.00 0.01 0.00 
ovary 002 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
testis 0,00 0.00 0.00 0.00 0.00 0.07 0.00 0.00 
uterus 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
urinary bladder 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
bone surface 0.05 0.17 0.02 0.00 0.01 0.00 0.99 0.38 
skin 0.05 0.17 0.02 0.00 0.00 0.00 0.98 0.38 
remainder organs 0.15 0.20 0.04 0.12 0.19 0.03 0.20 0.07 
 
Conclusions 
CBCT with DynaCT Artis Ceiling system for 
endobronchial navigation in the lung is adding a 
comparable low radiation exposure to the diagnostic 
process of possible malignancy in the lung. It is of-
fering some unique features like 1-step method of 
acquiring and applying the 3-dimensional dataset at 
the same time on the same table in the same place in 
comparison to EMN techniques. As an extrathoracical 
approach this system can be used to control as well 
therapeutic procedures endobronchially or transtho-
racically performed under realtime guidance. The 
open structure of a DynaCT is another advantage over 
closed MDCT-navigation-systems. Therefore the high 
feasibility as true multifunctional realtime navigation 
tool for diagnostic and therapeutic purposes justifies a 
widespread use even with low additional patient’s 
radiation exposure. 
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